Does Pregabalin, as an Adjuvance to Intravenous Opioids, Has an Additive/ Synergistic Effect on Pain Relief, Respiratory Depression, Sedation and Cognitive Function? A RCT on Healthy Volunteers.
Phase of Trial: Phase IV
Latest Information Update: 08 Apr 2014
At a glance
- Drugs Pregabalin (Primary) ; Remifentanil (Primary)
- Indications Pain
- Focus Therapeutic Use
- 17 Feb 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 17 Feb 2012 Actual initiation date (Dec 2011) added as reported by ClinicalTrials.gov.
- 23 Aug 2011 New trial record